Evidence map›Paper›PMID 32315486›Full record

ArticleChemistry (Weinheim an der Bergstrasse, Germany)2020

Modular Medical Imaging Agents Based on Azide-Alkyne Huisgen Cycloadditions: Synthesis and Pre-Clinical Evaluation of

Verena I Böhmer, Wiktor Szymanski, Keimpe-Oeds van den Berg, Chantal Mulder, Piermichele Kobauri, Hugo Helbert, Dion van der Born, Friederike Reeβing, Anja Huizing, Marten Klopstra and 8 more

Erratum issuedOpen access · hybridAbstract read
In one paragraph

Article in Chemistry (Weinheim an der Bergstrasse, Germany), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Article
  3. Structure-activity relationship ofEJNMMI radiopharmacy and chemistry · 2025
    Article
  4. The development ofEJNMMI radiopharmacy and chemistry · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Ultrafast Photoclick Reaction for SelectiveJournal of the American Chemical Society · 2021
    Article
  9. Article
  10. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors at 4 institutions in 1 country.

Verena I BöhmerDepartment of Nuclear Medicine and Molecular Imaging, Department of Radiology, Department of Surgical Oncology, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9713 GZ, Groningen, The Netherlands.
Wiktor SzymanskiDepartment of Nuclear Medicine and Molecular Imaging, Department of Radiology, Department of Surgical Oncology, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9713 GZ, Groningen, The Netherlands.ORCID http://orcid.org/0000-0002-9754-9248
Keimpe-Oeds van den BergDepartment of Nuclear Medicine and Molecular Imaging, Department of Radiology, Department of Surgical Oncology, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9713 GZ, Groningen, The Netherlands.
Chantal MulderDepartment of Nuclear Medicine and Molecular Imaging, Department of Radiology, Department of Surgical Oncology, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9713 GZ, Groningen, The Netherlands.
Piermichele KobauriStratingh Institute for Chemistry, University of Groningen, Nijenborgh 4, 9747 AF, Groningen, The Netherlands.
Hugo HelbertDepartment of Nuclear Medicine and Molecular Imaging, Department of Radiology, Department of Surgical Oncology, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9713 GZ, Groningen, The Netherlands.
Dion van der BornFutureChemistry, Toernooiveld 100, 6525 EC, Nijmegen, The Netherlands.
Friederike ReeβingDepartment of Nuclear Medicine and Molecular Imaging, Department of Radiology, Department of Surgical Oncology, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9713 GZ, Groningen, The Netherlands.
Anja HuizingDepartment of Nuclear Medicine and Molecular Imaging, Department of Radiology, Department of Surgical Oncology, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9713 GZ, Groningen, The Netherlands.
Marten KlopstraSyncom, Kadijk 3, 9747 AT, Groningen, The Netherlands.
Douwe F SamploniusDepartment of Nuclear Medicine and Molecular Imaging, Department of Radiology, Department of Surgical Oncology, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9713 GZ, Groningen, The Netherlands.
Ines F AntunesDepartment of Nuclear Medicine and Molecular Imaging, Department of Radiology, Department of Surgical Oncology, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9713 GZ, Groningen, The Netherlands.
Jürgen W A SijbesmaDepartment of Nuclear Medicine and Molecular Imaging, Department of Radiology, Department of Surgical Oncology, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9713 GZ, Groningen, The Netherlands.
Gert LuurtsemaDepartment of Nuclear Medicine and Molecular Imaging, Department of Radiology, Department of Surgical Oncology, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9713 GZ, Groningen, The Netherlands.
Wijnand HelfrichDepartment of Nuclear Medicine and Molecular Imaging, Department of Radiology, Department of Surgical Oncology, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9713 GZ, Groningen, The Netherlands.ORCID http://orcid.org/0000-0001-7004-3995
Ton J VisserSyncom, Kadijk 3, 9747 AT, Groningen, The Netherlands.
Ben L FeringaStratingh Institute for Chemistry, University of Groningen, Nijenborgh 4, 9747 AF, Groningen, The Netherlands.ORCID http://orcid.org/0000-0003-0588-8435
Philip H ElsingaDepartment of Nuclear Medicine and Molecular Imaging, Department of Radiology, Department of Surgical Oncology, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9713 GZ, Groningen, The Netherlands.ORCID http://orcid.org/0000-0002-3365-4305
University Medical Center Groningen · NLRadiocommunications Agency · NLUniversity of Groningen · NLRadboud University Nijmegen · NL

Funding

Center for Medical Imaging North-East NetherlandsNederlandse Organisatie voor Wetenschappelijk Onderzoek Gravitation program FMSProvinces of Overijssel and Gelderland
6 · The paper itself

Abstract

Since the seminal contribution of Rolf Huisgen to develop the [3+2] cycloaddition of 1,3-dipolar compounds, its azide-alkyne variant has established itself as the key step in numerous organic syntheses and bioorthogonal processes in materials science and chemical biology. In the present study, the copper(I)-catalyzed azide-alkyne cycloaddition was applied for the development of a modular molecular platform for medical imaging of the prostate-specific membrane antigen (PSMA), using positron emission tomography. This process is shown from molecular design, through synthesis automation and in vitro studies, all the way to pre-clinical in vivo evaluation of fluorine-18- labeled PSMA-targeting 'F-PSMA-MIC' radiotracers (t

Indexed as

Cycloaddition ReactionRadioactive TracersAlkynesAzidesFluorine RadioisotopesHumansMalePositron-Emission TomographyProstatic NeoplasmsAlkynesAzidesFluorine-18Fluorine RadioisotopesRadioactive Tracerscancerclick chemistrycycloadditionsimaging agentspositron emission tomography

Identifiers

PMID32315486
PMCPMC7496508
OpenAlexW3016669909

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.